Cassava Sciences Inc

6
2
NEW
NAS:SAVA (USA)  
$ 25.81 -0.195 (-0.75%) 07:08 PM EST
At Loss
P/B:
6.55
Volume:
1.43M
Avg Vol (2M):
1.72M
Trade In:
Volume:
1.43M
At Loss
Avg Vol (2M):
1.72M

Business Description

Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.78
Interest Coverage No Debt
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 22.31
9-Day RSI 35.92
14-Day RSI 42.36
6-1 Month Momentum % 32.87
12-1 Month Momentum % 46.05

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.07
Quick Ratio 4.07
Cash Ratio 3.8

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.2

Financials (Next Earnings Date:2024-11-07 Est.)

SAVA's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SAVA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cassava Sciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.41
Beta -1.27
Volatility % 99.92
14-Day RSI 42.36
14-Day ATR ($) 1.759954
20-Day SMA ($) 27.17475
12-1 Month Momentum % 46.05
52-Week Range ($) 8.79 - 42.2
Shares Outstanding (Mil) 47.98

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cassava Sciences Inc Filings

Filing Date Document Date Form
No Filing Data

Cassava Sciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Cassava Sciences Inc Frequently Asked Questions

What is Cassava Sciences Inc(SAVA)'s stock price today?
The current price of SAVA is $25.81. The 52 week high of SAVA is $42.20 and 52 week low is $8.79.
When is next earnings date of Cassava Sciences Inc(SAVA)?
The next earnings date of Cassava Sciences Inc(SAVA) is 2024-11-07 Est..
Does Cassava Sciences Inc(SAVA) pay dividends? If so, how much?
Cassava Sciences Inc(SAVA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1